Clinical Trial Update: Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase study evaluating intraventricular combination therapy with azacitidine and trastuzumab for recurrent or residual posterior fossa ependymoma; complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• Posterior Fossa Ependymoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Fossa Ependymoma | EARLY_Phase 1 | Status: COMPLETED